NCT05905016 Prospective Evaluation of the Clinical Utility of Peroral Endoscopic Myotomy for Gastrointestinal Motility Disorders
| NCT ID | NCT05905016 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AdventHealth |
| Condition | Achalasia |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2021-10-01 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2021-10-01 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is prospective data recording study. All patients will receive standard medical care and no experimental interventions will be performed.
Eligibility Criteria
Inclusion Criteria: 1. Age 18 years or older. 2. Scheduled to undergo POEM Exclusion Criteria: 1. Any contraindication to performing endoscopy. 2. Participation in another research protocol that could interfere or influence the outcomes measures of the present study.
Contact & Investigator
Dennis Yang, MD
PRINCIPAL INVESTIGATOR
AdventHealth Orlando
Frequently Asked Questions
Who can join the NCT05905016 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Achalasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05905016 currently recruiting?
Yes, NCT05905016 is actively recruiting participants. Contact the research team at Dennis.Yang.MD@adventhealth.com for enrollment information.
Where is the NCT05905016 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT05905016 clinical trial?
NCT05905016 is sponsored by AdventHealth. The principal investigator is Dennis Yang, MD at AdventHealth Orlando. The trial plans to enroll 600 participants.